The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending authorization in a narrower population than it previously considered …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
What You Should Know: – H1, the go-to resource for healthcare professionals, clinical trial information, and life sciences research, announced the launch of its conversational
A 68-year-old man with HIV-1 who underwent hematopoietic cell transplant (HCT) for acute myelogenous leukemia 5 years ago has been free of HIV infection for
Senate Finance Chair Ron Wyden (D-OR) is pressing Pfizer over its tax practices as part of his investigation into how large pharma companies use subsidiaries